Variations in tryptophan fluorescence intensities confirm that copper(II) interacts with α-synuclein, a protein implicated in Parkinson’s disease. Trp4 fluorescence decay kinetics measured for the F4W protein show that Cu(II) binds tightly (K_d ∼ 100 nM) near the N-terminus at pH 7. Work on a F4W/H50S mutant indicates that a histidine imidazole is not a ligand in this high-affinity site
Alterations in the levels of copper in brain tissue and formation of α-synuclein (αS)-copper complex...
Alterations in the levels of copper in brain tissue and formation of α-synuclein (αS)-copper complex...
The aggregation of alpha-synuclein (AS) is a critical step in the etiology of Parkinson’s disease (P...
The aggregation of α -synuclein (AS) is characteristic of Parkinson’s disease and other neurodegener...
Parkinsons disease (PD) is a neurodegenerative disorder characterized by the presence of abnormal α-...
Parkinson’s disease is characterized by the accumulation of neuronal deposits comprising largely the...
Parkinson's disease (PD) is a neurodegenerative disorder characterized by the presence of abnormal α...
The aggregation of α-synuclein (αS) is a critical step in the etiology of Parkinson’s disease. Metal...
The interaction between α-synuclein (αSyn) and Cu2+ has been suggested to be closely linked to brain...
Copper binding to α-synuclein (aS) and to amyloid-β (Ab) has been connected to Parkinson's and Alzhe...
Parkinson’s disease (PD) is a neurodegenerative disorder characterized by the presence of abnormal α...
Background: Copper is an essential trace element required for the proper functioning of various enzy...
The aggregation of alpha-synuclein (alpha S) is a critical step in the etiology of Parkinson's disea...
Copper (Cu) ion dys-homeostasis and α-synclein amyloid deposits are two hallmarks of Parkinson\u27s ...
The amyloid aggregation of alpha-synuclein (AS) has been linked to the pathological effects associat...
Alterations in the levels of copper in brain tissue and formation of α-synuclein (αS)-copper complex...
Alterations in the levels of copper in brain tissue and formation of α-synuclein (αS)-copper complex...
The aggregation of alpha-synuclein (AS) is a critical step in the etiology of Parkinson’s disease (P...
The aggregation of α -synuclein (AS) is characteristic of Parkinson’s disease and other neurodegener...
Parkinsons disease (PD) is a neurodegenerative disorder characterized by the presence of abnormal α-...
Parkinson’s disease is characterized by the accumulation of neuronal deposits comprising largely the...
Parkinson's disease (PD) is a neurodegenerative disorder characterized by the presence of abnormal α...
The aggregation of α-synuclein (αS) is a critical step in the etiology of Parkinson’s disease. Metal...
The interaction between α-synuclein (αSyn) and Cu2+ has been suggested to be closely linked to brain...
Copper binding to α-synuclein (aS) and to amyloid-β (Ab) has been connected to Parkinson's and Alzhe...
Parkinson’s disease (PD) is a neurodegenerative disorder characterized by the presence of abnormal α...
Background: Copper is an essential trace element required for the proper functioning of various enzy...
The aggregation of alpha-synuclein (alpha S) is a critical step in the etiology of Parkinson's disea...
Copper (Cu) ion dys-homeostasis and α-synclein amyloid deposits are two hallmarks of Parkinson\u27s ...
The amyloid aggregation of alpha-synuclein (AS) has been linked to the pathological effects associat...
Alterations in the levels of copper in brain tissue and formation of α-synuclein (αS)-copper complex...
Alterations in the levels of copper in brain tissue and formation of α-synuclein (αS)-copper complex...
The aggregation of alpha-synuclein (AS) is a critical step in the etiology of Parkinson’s disease (P...